Mother to hid transmission of HIV –
**Core Concept**
The question is testing the understanding of mother-to-child transmission (MTCT) of HIV, a significant concern in obstetric and pediatric medicine. MTCT occurs when HIV is transmitted from an infected mother to her child during pregnancy, childbirth, or breastfeeding.
**Why the Correct Answer is Right**
The correct answer is related to the use of antiretroviral therapy (ART) to prevent MTCT. ART works by suppressing the replication of HIV in the mother's body, thereby reducing the viral load and the risk of transmission to the child. This is achieved through the use of combination therapy, which typically includes a combination of nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase inhibitors (INIs). The goal is to maintain the mother's viral load below a certain threshold (usually <50 copies/mL) to minimize the risk of transmission.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specify a particular antiretroviral drug or regimen. While antiretroviral therapy is essential in preventing MTCT, the question is likely seeking a more specific answer.
* **Option B:** This option is incorrect because it does not address the mechanism of preventing MTCT. While avoiding breastfeeding may be a strategy to prevent MTCT, it is not the primary method of preventing transmission.
* **Option C:** This option is incorrect because it is not a specific antiretroviral drug or regimen. While antiretroviral therapy is essential, the question is likely seeking a more specific answer.
**Clinical Pearl / High-Yield Fact**
It's essential to note that the World Health Organization recommends the use of ART to prevent MTCT, and the goal is to maintain the mother's viral load below 50 copies/mL. Additionally, the use of elective cesarean delivery before the onset of labor and before the rupture of membranes may also reduce the risk of MTCT.
**Correct Answer: A. Zidovudine (AZT) monotherapy is not the preferred choice for preventing MTCT, but the combination of Zidovudine with Lamivudine (3TC) and Nevirapine (NVP) is a common regimen used for this purpose.